PHARMING GROUP NV - ADR (PHAR) Stock Analyst Ratings
USA - NASDAQ:PHAR - US71716E1055 - ADR
13.33 USD
-0.27 (-1.99%)
ChartMill assigns a Buy % Consensus number of 88% to PHAR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.3. This target is 59.76% above the current price.
PHAR was analyzed by 13 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about PHAR.
In the previous month the buy percentage consensus was at a similar level.
PHAR was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-14 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-09 | Jefferies | Initiate | Buy |
| 2024-10-28 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-28 | Oppenheimer | Maintains | Outperform |
| 2023-03-27 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-22 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-16 | HC Wainwright & Co. | Reiterate | Buy |
PHARMING GROUP NV - ADR / PHAR FAQ
What do analysts expect the price target to be for PHARMING GROUP NV - ADR (PHAR)?
13 analysts have analysed PHAR and the average price target is 21.3 USD. This implies a price increase of 59.76% is expected in the next year compared to the current price of 13.33.
What is the consensus rating for PHARMING GROUP NV - ADR (PHAR) stock?
The consensus rating for PHARMING GROUP NV - ADR (PHAR) is 87.6923 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for PHAR stock?
The number of analysts covering PHARMING GROUP NV - ADR (PHAR) is 13.